Clinical Trial Update: Clinical Trial Through Combined tACS Therapy in Patients With Mild Cognitive Impairment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating combined tACS therapy in patients with mild cognitive impairment is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: Universidad del Desarrollo | Conditions: Mild Cognitive Impairment | Phase 2 | Status: UNKNOWN